Bridgeway Capital Management, LLC Applied Therapeutics Inc. Transaction History

Bridgeway Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.35 - $8.5 $369,749 - $722,500	-85,000 Reduced 57.12%	63,800 $542,000
Q2 2024 Aug 14, 2024	SELL	$4.04 - $6.37 $101,000 - $159,250	-25,000 Reduced 14.38%	148,800 $694,000
Q1 2024 May 15, 2024	SELL	$2.25 - $7.4 $45,000 - $148,000	-20,000 Reduced 10.32%	173,800 $1.18 Million
Q4 2023 Feb 14, 2024	BUY	$1.84 - $3.35 $92,000 - $167,500	50,000 Added 34.77%	193,800 $649,000
Q3 2023 Nov 14, 2023	BUY	$1.26 - $2.77 $31,500 - $69,250	25,000 Added 21.04%	143,800 $358,000
Q1 2023 May 15, 2023	BUY	$0.75 - $1.21 $45,000 - $72,600	60,000 Added 102.04%	118,800 $96,000
Q4 2022 Feb 14, 2023	SELL	$0.54 - $1.12 $27,000 - $56,000	-50,000 Reduced 45.96%	58,800 $44,000
Q3 2022 Nov 14, 2022	BUY	$0.86 - $1.55 $43,000 - $77,500	50,000 Added 85.03%	108,800 $101,000
Q2 2022 Aug 15, 2022	SELL	$0.76 - $2.64 $38,000 - $132,000	-50,000 Reduced 45.96%	58,800 $56,000
Q1 2022 May 16, 2022	BUY	$1.48 - $6.22 $161,024 - $676,736	108,800 New	108,800 $230,000

130

112M

1.1M

800K

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $25.5M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.